Daewon Pharmaceutical Rises 5.18% Amid COVID-19 (Dexamethasone) Theme Uptrend

On the 6th, the COVID-19 (Dexamethasone) theme rose by 3.59% compared to the previous day, showing strength, while Daewon Pharmaceutical, which is attracting attention as a related stock, surged by 5.18% compared to the previous day. Daewon Pharmaceutical is known as a specialized pharmaceutical manufacturer focusing on therapeutic drugs.

[Graph] Major stock price changes in the COVID-19 (Dexamethasone) theme

According to provisional data compiled at 14:33, foreign investors have purchased 15,000 shares of Daewon Pharmaceutical, indicating a large net purchase by foreigners.

[Table] Net trading volume of foreigners and institutions (unit: 10,000 shares)

According to the analysis by Thinkpool Robo Algorithm RASSI, Daewon Pharmaceutical exceeded the average scores of the theme in growth, stability, and profitability, ranking 4th in the quant financial ranking (out of 15 stocks). This can be interpreted as Daewon Pharmaceutical having a relatively high investment attractiveness compared to other stocks within the theme from a financial perspective.

[Table] Top stocks by financial score within the theme

※ The quant financial score is the result of the robo algorithm analyzing each company's sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.